FindTrial
Sign In

A multicenter retrospective study on the efficacy and safety of ECMO in the treatment of high-risk pulmonary embolism

A multicenter retrospective study on the efficacy and safety of ECMO in the treatment of high-risk pulmonary embolism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117238
Enrollment
Unknown
Registered
2026-01-21
Start date
2026-01-28
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary embolism

Interventions

Observation group:N/A

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Confirmed acute PE patients with persistent hypotension, shock, or cardiac arrest who meet the 2019 ESC guideline high-risk PE criteria; 2.Age >=18 years old.

Exclusion criteria

Exclusion criteria: 1.Non-thrombotic pulmonary embolism (e.g., air embolism, fat embolism); 2.ECMO support for non-PE related cardiopulmonary failure; 3.Missing key baseline or outcome data; 4.Hospital stay < 24 hours or voluntary discharge.

Design outcomes

Primary

MeasureTime frame
Death or not;Whether major bleeding occurred;—

Countries

China

Contacts

Public ContactChen Hong

The First Affiliated Hospital of Chongqing Medical University

cychenhong@126.com+86 186 8080 2072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026